Davis Todd C (CIK 0001392029)

Latest company ownership

Shares held
161,467
Last filed at
Jul 2, 2025
Confidence Score
52.9
2025Q4
Confidence Score History
2014Q1 2025Q4
VXRT - Vaxart, Inc.
Role: Director
Shares held
44,224
Last filed at
Aug 8, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 30, 2025 Jul 2, 2025 LIGAND PHARMACEUTICALS INC CEO Buy 56.3 +233 0.14% ✗ $21.2K
May 9, 2025 May 13, 2025 LIGAND PHARMACEUTICALS INC CEO Buy 95.0 +9,510 6.27% ✗ $1M
Feb 14, 2025 Feb 19, 2025 LIGAND PHARMACEUTICALS INC CEO Sell 95.0 +7,332 5.96% ✗ $1.6M
Aug 8, 2024 Aug 9, 2024 LIGAND PHARMACEUTICALS INC CEO Buy 82.5 +2,500 2.07% ✗ $243.5K
Jun 28, 2024 Jul 2, 2024 LIGAND PHARMACEUTICALS INC CEO Buy 61.3 +350 0.29% ✗ $21.2K
Feb 15, 2024 Feb 16, 2024 LIGAND PHARMACEUTICALS INC CEO Sell 22.5 -1,381 -1.89% ✗ $103.1K
Sep 22, 2023 Sep 25, 2023 LIGAND PHARMACEUTICALS INC CEO Buy 90.0 +4,000 5.79% ✗ $237.5K
Jun 9, 2023 Jun 13, 2023 LIGAND PHARMACEUTICALS INC CEO Sell 36.3 -420 -0.60% ✗ $31K
Feb 10, 2021 Feb 12, 2021 LIGAND PHARMACEUTICALS INC Director Sell 17.5 -5,083 -9.63% ✗ $1.1M
Apr 28, 2020 Apr 30, 2020 Vaxart, Inc. Director Sell 22.5 -60,000 -33.33% ✗ $196.5K
Aug 2, 2019 Aug 5, 2019 LIGAND PHARMACEUTICALS INC Director Buy 82.5 +1,000 2.06% ✗ $93.6K
Oct 8, 2018 Oct 9, 2018 LIGAND PHARMACEUTICALS INC Director Sell 30.0 -2,500 -5.55% ✓ $635K
Aug 16, 2018 Aug 17, 2018 LIGAND PHARMACEUTICALS INC Director Sell 17.5 -9,000 -16.65% ✗ $2.2M
Feb 26, 2018 Feb 27, 2018 LIGAND PHARMACEUTICALS INC Director Sell 17.5 -17,170 -24.27% ✗ $2.6M
Mar 18, 2014 Mar 20, 2014 LIGAND PHARMACEUTICALS INC Director Sell 20.0 -7,500 -18.73% ✗ $596.8K